Form 4: Opaleye Management Boosts Alpha Cognition Stake

Sentiment:

Insider Transaction Report


Opaleye Management Inc., a 10% owner and director, significantly increased its indirect beneficial ownership in Alpha Cognition Inc. through multiple common stock purchases in late February 2026.

Better than expectedA significant insider, who is also a director and 10% owner, increased their stake in the company.Insider buying often signals confidence in the company's future prospects and can be viewed positively by the market.

Summary

  • Opaleye Management Inc., acting as an investment manager for Opaleye, L.P. and a portfolio manager for a Managed Account, acquired additional common stock of Alpha Cognition Inc.
  • On February 20, 2026, 12,819 shares were purchased at a weighted average price of $5.8411 per share.
  • On February 23, 2026, 100,000 shares were purchased at a weighted average price of $5.8923 per share.
  • On February 24, 2026, 58,591 shares were purchased at a weighted average price of $5.8004 per share.
  • Following these transactions, Opaleye Management Inc. indirectly beneficially owns a total of 2,364,410 shares of Alpha Cognition Inc. common stock.
  • The purchases were made through Opaleye, L.P. (2,284,410 shares) and a separately managed account (80,000 shares).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development. Significant insider buying by a director and 10% owner typically indicates strong internal confidence in the company's valuation and future performance, though it's a transactional report without operational updates.

Positives

  • A significant insider, Opaleye Management Inc., which is also a director and 10% owner, increased its stake in Alpha Cognition Inc., signaling confidence in the company's future prospects.
  • The purchases occurred over three separate days, indicating a sustained buying interest.
  • The total acquisition of 171,410 shares represents a notable increase in their existing substantial holding.

Risks

  • The prices reported are weighted average prices, and actual purchase prices varied within specified ranges ($5.75-$5.85, $5.59-$5.99, $5.615-$5.95), indicating potential price volatility during the acquisition period.
  • Opaleye Management Inc. disclaims beneficial ownership except to the extent of its pecuniary interest, which could imply a nuanced view on their direct control or influence over all reported shares.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance, as it is a transactional report.

Management Comments

  • Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Industry Context

StockSavvy.ai notes that insider buying, especially from a significant shareholder and director, can often be interpreted by the market as a positive signal, suggesting that those with intimate knowledge of the company believe its stock is undervalued or that positive developments are anticipated. This activity occurs within the broader context of the biotechnology or pharmaceutical industry, where company-specific news often drives stock performance.

Related Party Transactions

  • The transactions involve Opaleye Management Inc. (reporting person, director, 10% owner) acquiring shares indirectly through Opaleye, L.P. and a Managed Account, for which it acts as investment/portfolio manager. This constitutes a related party transaction as the reporting person has influence over these entities.

Stakeholder Impact

  • Shareholders: May view the insider buying as a positive signal, potentially increasing confidence and demand for the stock.
  • Management: The increased stake by a director and 10% owner could align interests further, potentially influencing strategic decisions.

Key Dates

DateDescription
02/20/2026Purchase of 10,000 shares by Opaleye, L.P. and 2,819 shares by Managed Account.
02/23/2026Purchase of 95,819 shares by Opaleye, L.P. and 4,181 shares by Managed Account.
02/24/2026Purchase of 53,591 shares by Opaleye, L.P. and 5,000 shares by Managed Account. This is also the filing date.

Recommendation

hold

The insider buying by a significant shareholder and director is a positive signal, indicating confidence in Alpha Cognition Inc. However, a Form 4 filing alone does not provide sufficient operational or financial details to warrant a 'buy' recommendation without further fundamental analysis. It primarily suggests that existing shareholders should 'hold' as a key insider is increasing their position, implying potential future upside.

Keywords

Alpha Cognition Inc., ACOG, Opaleye Management Inc., Insider Buying, Form 4, Beneficial Ownership, Stock Purchase, Director, 10% Owner, Investment Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.